Cargando…
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
BACKGROUND: HO-1 participates in the degradation of heme. Its products can exert unique cytoprotective effects. Numerous tumors express high levels of HO-1 indicating that this enzyme might be a potential therapeutic target. In this study we decided to evaluate potential cytostatic/cytotoxic effects...
Autores principales: | Nowis, Dominika, Bugajski, Marek, Winiarska, Magdalena, Bil, Jacek, Szokalska, Angelika, Salwa, Pawel, Issat, Tadeusz, Was, Halina, Jozkowicz, Alicja, Dulak, Jozef, Stoklosa, Tomasz, Golab, Jakub |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478682/ https://www.ncbi.nlm.nih.gov/pubmed/18620555 http://dx.doi.org/10.1186/1471-2407-8-197 |
Ejemplares similares
-
Heme oxygenase inhibition in cancers: possible tools and targets
por: Podkalicka, Paulina, et al.
Publicado: (2018) -
Inhibition of Heme Oxygenase-1 by Zinc Protoporphyrin IX Improves Adverse Pregnancy Outcomes in Malaria During Early Gestation
por: Cariaco, Yusmaris, et al.
Publicado: (2022) -
Interactions Between the Circadian Clock and Heme Oxygenase in the Retina of Drosophila melanogaster
por: Damulewicz, Milena, et al.
Publicado: (2016) -
Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
por: Winiarska, Magdalena, et al.
Publicado: (2008) -
Cobalt protoporphyrin IX increases endogenous G‐CSF and mobilizes HSC and granulocytes to the blood
por: Szade, Agata, et al.
Publicado: (2019)